While Craig said he expects funds under management will continue to show steady growth, the market was generally softer.
Fisher Funds has a diametrically opposed view of the company from Healthcare Partners.
They'll let the grumblings and dissatisfaction with the partial offer increase....and leverage the fair value at $10 for a full offer...and everyone can start the new year with some cash in their pockets... They will have no problem "reselling" 49%
Consensus forecast downgrades likely, analyst says.
F&P Healthcare undoubtedly is one of the best companies to invest in. Long term gains will offset these short term roadblocks.